|
Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease Hypertens (Apr 2009)
|
|
The genetic basis of kidney disease risk in African Americans: MYH9 as a new candidate gene Am J Kidney Dis (Apr 2009)
|
|
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med (Mar 2009)
|
|
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis Clin J Am Soc Nephrol (Mar 2009)
|
|
Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD? Am J Kidney Dis (Feb 2009)
|
|
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study Am J Kidney Dis (Feb 2009)
|
|
More is not always better: intensive glycemic control in type 2 diabetes Am J Kidney Dis (Jan 2009)
|
|
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the ADA and the Eur Assoc Study Diab Diabet Care (Jan 2009)
|
|
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the ADA, ACCF, and AHA. Diabet Care (Jan 2009)
|
|
Chronic kidney disease at high altitude J Am Soc Nephrol (Dec 2008)
|
|
Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy? Nature Clin Pract Nephrol (Dec 2008)
|
|
American College of Endocrinology Pre-Diabetes Consensus Conference: Part Three Diabet Care (Dec 2008)
|
|
Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies Am J Clin Nutr (Nov 2008)
|
|
American College of Endocrinology pre-diabetes consensus conference: part one Diabet Care (Oct 2008)
|
|
Passive smoking and risk of peripheral arterial disease and ischemic stroke in chinese women who never smoked Circulation (Oct 2008)
|
|
Glycated hemoglobin or glycated albumin for assessment of glycemic control in hemodialysis patients with diabetes? Nature Clin Pract Nephrol (Sep 2008)
|
|
Balkan nephropathy: evolution of our knowledge Am J Kidney Dis (Sep 2008)
|
|
Oral estrogen therapy in postmenopausal women is associated with loss of kidney function Kidney Int (Aug 2008)
|
|
Translating the A1C assay into estimated average glucose values Diabet Care (Aug 2008)
|
|
The aggravating mechanisms of aldosterone on kidney fibrosis J Am Soc Nephrol (Aug 2008)
|
|
Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association. Circulation (Jul 2008)
|
|
Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: A Scientific Statement From American Heart Association (Kumanyika SK et al) Circulation Jul 08
|
|
Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: A Scientific Statement From American Heart Association Circulation (Jul 2008)
|
|
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease Clin J Am Soc Nephrol (Jul 2008)
|
|
Debate: Weight loss and blood pressure control (Pro) vs. Dietary therapy for obesity: an emperor with no clothes (Con) Hypertens (Jun 2008)
|
|
Large artery stiffening with weight gain in humans: role of visceral fat accumulation Hypertens (Jun 2008)
|
|
Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med (Jun 2008)
|
|
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care Diabet Care (May 2008)
|
|
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med (May 2008)
|
|
Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation Diabet Care (Apr 2008)
|
|
Hyperglycemia and acute coronary syndrome: A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation (Mar 2008)
|
|
Adiponectin, cardiovascular function, and hypertension Hypertens (Jan 2008)
|
|
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: Update regarding thiazolidinediones: a consensus statement from the ADA/EASD Diabet Care (Jan 2008)
|
|
Long term pharmacotherapy for obesity and overweight: updated meta-analysis (Rucker et al) Brit Med J (Dec 2007)
|
|
Rosiglitazone decreases albuminuria in type 2 diabetic patients (Miyazaki et al) Kidney Int (Dec 2007)
|
|
2007 Chronic angina focused update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina: A Report of the ACC/AHA Task Force (Fraker Jr et al) Diabet Care (Dec 2007)
|
|
Obesity paradox in patients with hypertension and coronary artery disease (Lavie et al) Am J Med (Oct 2007)
|
|
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review (Eurich et al) Brit Med J (Sep 2007)
|
|
Impact of glucose levels on advanced glycation end products in hemodialysis (Godfrey) Hemodial Int (Jul 2007)
|
|
Intensive versus moderate blood-pressure control in normotensive patients with type 2 diabetes (Briggs J) NCPN Jun 07
|
|
Hypomagnesemia in patients with type 2 diabetes CJASN 03-07
|
|
Hypomagnesemia in patients with type 2 diabetes (Pham et al) CJASN (03-2007)
|
|
KDOQI Clinical Practice Guidelines and CPRs (2006 update) for Treatment of Diabetes and CKD AJKD (Feb 07)
|
|
(2006 Pharma )Year in Review (Michele B. Kaufman, PharmD, RPh) Dial-Transplant 12-06
|
|
Advanced glycation end products and nephrotoxicity of high-protein diets (Uribarri, Tuttle) CJASN 11-06
|
|
ACE2: A new target for prevention of diabetic nephropathy? (Ingelfinger JR, commenting on an article by Batlle's group) JASN 11-06
|
|
Angiotensin-converting enzyme-2 (ACE-2) - a new player in the genesis of glomerular injury? (Comment by Ritz on paper by Oudit et al) JASN 10-06
|
|
Management of dyslipidemias in patients with diabetes and chronic kidney disease (Molitch). CJASN 09-06
|